Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$567M |
| 2 |
Kroger
KR
|
+$566M |
| 3 |
AGN
Allergan plc
AGN
|
+$491M |
| 4 |
NXP Semiconductors
NXPI
|
+$366M |
| 5 |
Sherwin-Williams
SHW
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$880M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$731M |
| 3 |
CELG
Celgene Corp
CELG
|
+$395M |
| 4 |
AGN
Allergan Inc
AGN
|
+$320M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$309M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 14.7% |
| 3 | Technology | 12.89% |
| 4 | Communication Services | 12.45% |
| 5 | Financials | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DERM
501
DELISTED
Dermira, Inc.
DERM
| $7.79M | 0.01% |
507,703
-16,275
| -3% | -$273K |
|
|
ACT.PRA
502
DELISTED
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
| $7.59M | 0.01% |
+7,500
| New | +$7.85M |
|
|
CNCE
503
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $7.27M | 0.01% |
+480,222
| New | +$6.7M |
|
|
PSXP
504
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $7.15M | 0.01% |
101,200
-17,534
| -15% | -$1.26M |
|
|
NVRO
505
DELISTED
NEVRO CORP.
NVRO
| $6.95M | 0.01% |
144,946
-1,929
| -1% | -$83.7K |
|
|
RGLS
506
DELISTED
Regulus Therapeutics
RGLS
| $6.83M | 0.01% |
3,361
+10
| +0.3% | +$21.7K |
|
|
TEP
507
DELISTED
Tallgrass Energy Partners, LP
TEP
| $6.7M | 0.01% |
132,482
+11,981
| +10% | +$570K |
|
508
MPLX
MPLX
$58.5B
| $6.6M | 0.01% |
90,059
-23,918
| -21% | -$1.82M |
|
|
ESPR
509
DELISTED
Esperion Therapeutics
ESPR
| $6.49M | 0.01% |
+70,047
| New | +$4.52M |
|
|
CBAY
510
DELISTED
Cymabay Therapeutics
CBAY
| $6.37M | 0.01% |
921,155
-72,345
| -7% | -$695K |
|
|
ETP
511
DELISTED
Energy Transfer Partners L.p.
ETP
| $6.09M | 0.01% |
109,301
+12,163
| +13% | +$721K |
|
512
Ocular Therapeutix
OCUL
$1.85B
| $5.81M | 0.01% |
+138,418
| New | +$4.55M |
|
513
Webster Financial
WBS
$12.5B
| $5.73M | 0.01% |
154,649
-8,957
| -5% | -$301K |
|
514
Rocket Pharmaceuticals
RCKT
$351M
| $5.42M | 0.01% |
+250,230
| New | +$5.87M |
|
|
TRNX
515
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $5.39M | ﹤0.01% |
205,678
+657
| +0.3% | +$16.6K |
|
|
ROIC
516
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $5.22M | ﹤0.01% |
+285,219
| New | +$5.01M |
|
|
GWR
517
DELISTED
Genesee & Wyoming Inc.
GWR
| $5.16M | ﹤0.01% |
+53,496
| New | +$5M |
|
518
Asbury Automotive
ABG
$4.34B
| $5.03M | ﹤0.01% |
60,497
-106,584
| -64% | -$8.23M |
|
519
National Grid
NGG
$80.8B
| $4.96M | ﹤0.01% |
79,560
-7,695
| -9% | -$507K |
|
520
Valley National Bancorp
VLY
$7.92B
| $4.79M | ﹤0.01% |
507,659
+2,323
| +0.5% | +$22K |
|
521
ExxonMobil
XOM
$651B
| $4.75M | ﹤0.01% |
55,831
-266
| -0.5% | -$23.6K |
|
|
STAY
522
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $4.7M | ﹤0.01% |
240,751
-22,548
| -9% | -$448K |
|
|
EPZM
523
DELISTED
Epizyme, Inc
EPZM
| $4.7M | ﹤0.01% |
+250,138
| New | +$5.17M |
|
524
Verastem
VSTM
$536M
| $4.57M | ﹤0.01% |
37,465
+103
| +0.3% | +$10.8K |
|
525
Sunoco
SUN
$14.3B
| $4.47M | ﹤0.01% |
87,066
+16,655
| +24% | +$842K |
|
Similar funds
Jennison Associates's Q1 2015 Portfolio in Review
As of Q1 2015, Jennison Associates held 801 positions worth $109B, up 2.1% from $107B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q1 2015 filing shows 86 new, 297 increased, 319 reduced and 92 closed positions. Its largest new stake was NXP Semiconductors: 4,151,977 shares worth $417M. The largest sale was PRECISION CASTPARTS CORP, an estimated $880M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q1 2015 buy was NXP Semiconductors: 4,151,977 shares worth $417M.
- Jennison Associates added most to Time Warner Inc in Q1 2015, an estimated $567M increase.
- Jennison Associates's biggest Q1 2015 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $731M.
- Jennison Associates fully exited PRECISION CASTPARTS CORP in Q1 2015, selling an estimated $880M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q1 2015.
- Jennison Associates opened 86 new positions and closed 92 in Q1 2015.
- Jennison Associates's portfolio value rose 2.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2015, filed 4 May 2015.